This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified MechanismALS
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
9/11
dimensions won
SASP-Secreted MMP-9 from Senescent Micro
10/11
dimensions won
TBK1 Loss Locks Microglia in an Aged/Sen
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.50
0.50
Evidence
0.30
0.82
Novelty
0.88
0.82
Feasibility
0.72
0.80
Impact
0.50
0.50
Druggability
0.50
0.50
Safety
0.50
0.50
Competition
0.50
0.50
Data
0.50
0.50
Reproducible
0.50
0.50
KG Connect
0.50
0.50
Score Breakdown
Dimension
SASP-Secreted MMP-9 from Senes
TBK1 Loss Locks Microglia in a
Mechanistic
0.500
0.500
Evidence
0.300
0.820
Novelty
0.880
0.820
Feasibility
0.720
0.800
Impact
0.500
0.500
Druggability
0.500
0.500
Safety
0.500
0.500
Competition
0.500
0.500
Data
0.500
0.500
Reproducible
0.500
0.500
KG Connect
0.500
0.500
Evidence
SASP-Secreted MMP-9 from Senescent Microglia Generates Patho
No evidence citations yet
TBK1 Loss Locks Microglia in an Aged/Senescent Transcription
No evidence citations yet
Debate Excerpts
SASP-Secreted MMP-9 from Senescent Microglia Gener
6 rounds · quality: 0.75
Theorist
# Novel Therapeutic Hypotheses: Microglial Senescence in ALS
*Generated from systematic analysis of provided literature and cross-disciplinary synthesis*
---
## Hypothesis 1: TBK1-Deficiency Drives...
Skeptic
...
Domain Expert
...
Epidemiologist
...
TBK1 Loss Locks Microglia in an Aged/Senescent Tra
6 rounds · quality: 0.75
Theorist
# Novel Therapeutic Hypotheses: Microglial Senescence in ALS
*Generated from systematic analysis of provided literature and cross-disciplinary synthesis*
---
## Hypothesis 1: TBK1-Deficiency Drives...